PGL 0.00% 85.0¢ prospa group limited.

afr, page-14

  1. 160 Posts.
    So far it looks promising but the advanced melanoma market is of course much smaller than for liver cancer.

    I would say there is a greater than 50% chance of failure if it gets to Phase III. Or should I say a more than 40% chance of success :-)
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.